{"transactions":[{"id":770348,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-20T22:06:21.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0.7,"value":105000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date."}],"balance_after":150000,"derivative":{"exercise_price":0.7,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-26-064657","document":"tm267728-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465926064657/tm267728-5_4seq1.xml","form_type":"4"}},{"id":1315841,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T22:34:52.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock units (\"RSUs\") awarded under the 2014 Stock Incentive Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024."}],"balance_after":25730,"source":{"system":"sec-edgar","filing":"0001104659-25-000893","document":"tm251864-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465925000893/tm251864-8_4seq1.xml","form_type":"4"}},{"id":2414522,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-03T21:33:53.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded pursuant to the Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on March 1, 2022 until fully vested on the first anniversary of February 1, 2022, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date."}],"balance_after":25960,"source":{"system":"sec-edgar","filing":"0001104659-22-011390","document":"tm225365-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465922011390/tm225365-1_4seq1.xml","form_type":"4"}},{"id":2439905,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2022-01-07T21:30:34.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":74,"price":13.94,"value":1031.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased pursuant to the Issuer's Amended and Restated Employee Stock Purchase Plan (ESPP) for the ESPP purchase period July 1, 2021 through December 31, 2021. In accordance with the ESPP, these shares were purchased at a price equal to 85% the closing price of the Issuer's common shares on December 31, 2021."}],"balance_after":36407,"source":{"system":"sec-edgar","filing":"0000899243-22-001424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924322001424/doc4.xml","form_type":"4"}},{"id":2468048,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-17T22:03:22.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded in connection with the Company's 2021 Annual Meeting of Stockholders pursuant to the Company's Second Amended and Restated Director Compensation Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on January 15, 2022 until fully vested on the first anniversary of December 15, 2021."}],"balance_after":22078,"source":{"system":"sec-edgar","filing":"0001104659-21-151215","document":"tm2135659-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921151215/tm2135659-4_4seq1.xml","form_type":"4"}},{"id":2477588,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-11T01:03:30.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares acquired are shares of restricted stock awarded in connection with the Company's 2020 Annual Meeting of Stockholders pursuant to the Brainstorm Cell Therapeutics Inc. Second Amended and Restated Director Compensation Plan . The shares of restricted stock vested in 12 consecutive, equal monthly installments commencing on December 11, 2020 until fully vested on the first anniversary of November 11, 2020, provided that the reporting person remained a director of Brainstorm Cell Therapeutics on each vesting date."}],"balance_after":20078,"source":{"system":"sec-edgar","filing":"0001104659-21-148751","document":"tm2135032-6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921148751/tm2135032-6_4.xml","form_type":"4"}},{"id":2477587,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-11T01:03:30.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":2216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded pursuant to the Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on March 1, 2021 until fully vested on the first anniversary of February 1, 2021, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date."}],"balance_after":18078,"source":{"system":"sec-edgar","filing":"0001104659-21-148751","document":"tm2135032-6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465921148751/tm2135032-6_4.xml","form_type":"4"}},{"id":2581417,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-02T20:00:19.000Z","date":"2021-08-31","kind":"exercise","acquired":false,"shares":4900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of December 12, 2018, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date."}],"balance_after":77600,"derivative":{"exercise_price":15,"expiration_date":"2028-12-11","underlying":"Common Shares","underlying_shares":4900},"source":{"system":"sec-edgar","filing":"0000899243-21-034985","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924321034985/doc4.xml","form_type":"4"}},{"id":2581416,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2021-09-02T20:00:19.000Z","date":"2021-08-31","kind":"exercise","acquired":true,"shares":4900,"price":15,"value":73500.0,"ownership":{"direct":true},"balance_after":36333,"source":{"system":"sec-edgar","filing":"0000899243-21-034985","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924321034985/doc4.xml","form_type":"4"}},{"id":2637981,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2021-07-08T20:00:37.000Z","date":"2021-07-06","kind":"grant","acquired":true,"shares":454,"price":29.49,"value":13388.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased pursuant to the Issuer's Amended and Restated Employee Stock Purchase Plan (ESPP) for the ESPP purchase period January 1, 2021 through June 30, 2021. In accordance with the ESPP, these shares were purchased at a price equal to 85% the closing price of the Issuer's common shares on June 30, 2021."}],"balance_after":31433,"source":{"system":"sec-edgar","filing":"0000899243-21-027914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924321027914/doc4.xml","form_type":"4"}},{"id":2791716,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-03-12T20:00:40.000Z","date":"2021-03-10","kind":"grant","acquired":true,"shares":8125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest in three equal annual installments beginning on March 10, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest in three equal annual installments beginning on March 10, 2022."}],"balance_after":8125,"derivative":{"underlying":"Common Shares","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0000899243-21-011435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924321011435/doc4.xml","form_type":"4"}},{"id":2791715,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T20:00:40.000Z","date":"2021-03-10","kind":"grant","acquired":true,"shares":48750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date."}],"balance_after":48750,"derivative":{"exercise_price":34.82,"expiration_date":"2031-03-09","underlying":"Common Shares","underlying_shares":48750},"source":{"system":"sec-edgar","filing":"0000899243-21-011435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924321011435/doc4.xml","form_type":"4"}},{"id":2791714,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-03-12T20:00:40.000Z","date":"2021-03-10","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs were granted on March 10, 2020 and vest in three equal annual instalments beginning on March 10, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs were granted on March 10, 2020 and vest in three equal annual instalments beginning on March 10, 2021."}],"balance_after":5000,"derivative":{"underlying":"Common Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000899243-21-011435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924321011435/doc4.xml","form_type":"4"}},{"id":2791713,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2021-03-12T20:00:40.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":1048,"price":34.9535,"value":36631.268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents common shares sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs. Pursuant to the terms of the applicable RSU grant agreement (the \"Grant Agreement\"), effective on the grant date of the RSUs, the Reporting Person irrevocably adopted a 10b5-1 plan pursuant to which the Reporting Person elected to sell shares to cover tax withholding obligations and other applicable fees in accordance with the terms of the Grant Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.80 to $35.15, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":30979,"source":{"system":"sec-edgar","filing":"0000899243-21-011435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924321011435/doc4.xml","form_type":"4"}},{"id":2791712,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2021-03-12T20:00:40.000Z","date":"2021-03-10","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common shares issued upon vesting of one third of the restricted stock units (\"RSUs\") granted on March 10, 2020."}],"balance_after":32027,"source":{"system":"sec-edgar","filing":"0000899243-21-011435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924321011435/doc4.xml","form_type":"4"}},{"id":2910810,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2021-01-11T17:06:18.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":48,"price":30.92,"value":1484.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased pursuant to the Issuer's Amended and Restated Employee Stock Purchase Plan (ESPP) for the ESPP purchase period July 1, 2020 through December 31, 2020. In accordance with the ESPP, these shares were purchased at a price equal to 85% the closing price of the Issuer's common shares on July 1, 2020."}],"balance_after":29527,"source":{"system":"sec-edgar","filing":"0000899243-21-001344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924321001344/doc4.xml","form_type":"4"}},{"id":3088620,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2020-07-06T19:44:35.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":488,"price":30.66,"value":14962.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased pursuant to the Issuer's Amended and Restated Employee Stock Purchase Plan (ESPP) for the ESPP purchase period January 1, 2020 through June 30, 2020. In accordance with the ESPP, these shares were purchased at a price equal to 85% the closing price of the Issuer's common shares on June 30, 2020."}],"balance_after":29479,"source":{"system":"sec-edgar","filing":"0000899243-20-018549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924320018549/doc4.xml","form_type":"4"}},{"id":3215574,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-03-11T20:33:11.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning on March 10, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning on March 10, 2021."}],"balance_after":7500,"derivative":{"underlying":"Common Shares","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-20-008005","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924320008005/doc4.xml","form_type":"4"}},{"id":3215573,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-11T20:33:11.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date."}],"balance_after":45000,"derivative":{"exercise_price":35.2,"expiration_date":"2030-03-09","underlying":"Common Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-20-008005","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924320008005/doc4.xml","form_type":"4"}},{"id":3271251,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-14T22:00:27.000Z","date":"2020-02-01","kind":"grant","acquired":true,"shares":3071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares acquired are shares of restricted stock awarded on February 1, 2020 pursuant to the Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on March 1, 2020 until fully vested on the first anniversary of the date of grant, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date."}],"balance_after":15862,"source":{"system":"sec-edgar","filing":"0001104659-20-021983","document":"tm205737d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920021983/tm205737d3_4.xml","form_type":"4"}},{"id":3271250,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-14T22:00:27.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on December 12, 2019 pursuant to the Brainstorm Cell Therapeutics Inc. Second Amended and Restated Director Compensation Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on January 12, 2020 until fully vested on the first anniversary of the date of grant, provided that the reporting person remains a director (and committee member, as applicable) of Brainstorm Cell Therapeutics on each vesting date."}],"balance_after":12791,"source":{"system":"sec-edgar","filing":"0001104659-20-021983","document":"tm205737d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920021983/tm205737d3_4.xml","form_type":"4"}},{"id":3314473,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2020-01-09T16:06:35.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":371,"price":19.54,"value":7249.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased pursuant to the issuer's Amended and Restated Employee Stock Purchase Plan (ESPP) for the ESPP purchase period July 1, 2019 through December 31, 2019. In accordance with the ESPP, these shares were purchased at a price equal to 85% the closing price of the issuer's common shares on July 1, 2019."}],"balance_after":28991,"source":{"system":"sec-edgar","filing":"0000899243-20-000880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924320000880/doc4.xml","form_type":"4"}},{"id":3342228,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-13T16:17:25.000Z","date":"2019-12-12","kind":"exercise","acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of December 12, 2018, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date."}],"balance_after":82500,"derivative":{"exercise_price":15,"expiration_date":"2028-12-11","underlying":"Common Shares","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0000899243-19-029160","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924319029160/doc4.xml","form_type":"4"}},{"id":3342227,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2019-12-13T16:17:25.000Z","date":"2019-12-12","kind":"exercise","acquired":true,"shares":27500,"price":15,"value":412500.0,"ownership":{"direct":true},"balance_after":28620,"source":{"system":"sec-edgar","filing":"0000899243-19-029160","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924319029160/doc4.xml","form_type":"4"}},{"id":3464118,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2019-07-10T16:55:25.000Z","date":"2019-07-08","kind":"grant","acquired":true,"shares":1120,"price":12.49,"value":13988.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased pursuant to the issuer's Amended and Restated Employee Stock Purchase Plan (ESPP) for the ESPP purchase period January 1, 2019 through June 30, 2019. In accordance with the ESPP, these shares were purchased at a price equal to 85% the closing price of the issuer's common shares on January 2, 2019."}],"balance_after":1120,"source":{"system":"sec-edgar","filing":"0000899243-19-019436","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924319019436/doc4.xml","form_type":"4"}},{"id":3639080,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-22T22:00:42.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":3501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on February 1, 2019 pursuant to the Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on March 1, 2019 until fully vested on the first anniversary of the date of grant, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date."}],"balance_after":10791,"source":{"system":"sec-edgar","filing":"0001144204-19-009627","document":"tv514175_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420419009627/tv514175_form4.xml","form_type":"4"}},{"id":3698112,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-10T16:23:47.000Z","date":"2019-01-08","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date."}],"balance_after":75000,"derivative":{"exercise_price":15.53,"expiration_date":"2029-01-07","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-19-000964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924319000964/doc4.xml","form_type":"4"}},{"id":3747802,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-30T22:05:15.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7290,"source":{"system":"sec-edgar","filing":"0001144204-18-062654","document":"tv507905_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420418062654/tv507905_4.xml","form_type":"4"}},{"id":3747801,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-30T22:05:15.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on November 30, 2018 pursuant to the Brainstorm Cell Therapeutics Inc. Second Amended and Restated Director Compensation Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on December 30, 2018 until fully vested on the first anniversary of the date of grant, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date."}],"balance_after":5623,"source":{"system":"sec-edgar","filing":"0001144204-18-062654","document":"tv507905_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420418062654/tv507905_4.xml","form_type":"4"}},{"id":4076660,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45750,"kind":"person","name":"Polverino Anthony J.","position":1,"cik":"0001729957","reported_name":"Polverino Anthony J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-05T21:30:37.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":3623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on February 1, 2018 pursuant to the Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on March 1, 2018 until fully vested on the first anniversary of the date of grant, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date."}],"balance_after":3623,"source":{"system":"sec-edgar","filing":"0001144204-18-005728","document":"tv484711_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420418005728/tv484711_4.xml","form_type":"4"}}]}